Hongyin Sun

689 total citations · 1 hit paper
12 papers, 304 citations indexed

About

Hongyin Sun is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Hongyin Sun has authored 12 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Immunology. Recurrent topics in Hongyin Sun's work include Cancer Immunotherapy and Biomarkers (3 papers), Protein Degradation and Inhibitors (3 papers) and Immunotherapy and Immune Responses (2 papers). Hongyin Sun is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Protein Degradation and Inhibitors (3 papers) and Immunotherapy and Immune Responses (2 papers). Hongyin Sun collaborates with scholars based in China, Canada and United States. Hongyin Sun's co-authors include Mingzhu Yin, Muhammad Sajid Hamid Akash, Kanwal Rehman, Shuqing Chen, Xiang Chen, Rui Hu, Ying Guo, Yao Li, Yongguang Tao and Jiali Li and has published in prestigious journals such as Nature, Nature Communications and Frontiers in Microbiology.

In The Last Decade

Hongyin Sun

10 papers receiving 301 citations

Hit Papers

Tumour vasculature at single-cell resolution 2024 2026 2025 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongyin Sun China 8 180 79 70 36 32 12 304
Gatha Thacker India 12 223 1.2× 138 1.7× 84 1.2× 79 2.2× 32 1.0× 20 367
Nayer Seyfizadeh Iran 10 116 0.6× 40 0.5× 53 0.8× 45 1.3× 22 0.7× 17 289
Rebecca E. Parker United States 12 179 1.0× 70 0.9× 129 1.8× 27 0.8× 70 2.2× 23 398
Ebru Aydin Sweden 12 139 0.8× 90 1.1× 191 2.7× 47 1.3× 34 1.1× 22 388
Bingmu Fang China 9 136 0.8× 141 1.8× 98 1.4× 83 2.3× 39 1.2× 20 339
Miaorong She China 10 254 1.4× 118 1.5× 38 0.5× 48 1.3× 51 1.6× 15 389
Tianhang Zhai China 11 159 0.9× 64 0.8× 155 2.2× 30 0.8× 15 0.5× 15 360
Savita Bhalla United States 9 211 1.2× 109 1.4× 56 0.8× 37 1.0× 30 0.9× 19 355
Yuyang Tian China 8 128 0.7× 118 1.5× 45 0.6× 83 2.3× 28 0.9× 20 302

Countries citing papers authored by Hongyin Sun

Since Specialization
Citations

This map shows the geographic impact of Hongyin Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongyin Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongyin Sun more than expected).

Fields of papers citing papers by Hongyin Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongyin Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongyin Sun. The network helps show where Hongyin Sun may publish in the future.

Co-authorship network of co-authors of Hongyin Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Hongyin Sun. A scholar is included among the top collaborators of Hongyin Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongyin Sun. Hongyin Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Xu, Wenlong, Xiaohong Chen, Chen Xu, et al.. (2025). Gut microbiota and colorectal cancer: mechanistic insights, diagnostic advances, and microbiome-based therapeutic strategies. Frontiers in Microbiology. 16. 1699893–1699893.
2.
Lv, Chao, Lei Zhao, Jinlin Hou, et al.. (2025). Multi-omics reveals total flavones from Abelmoschus manihot (L.) Medik. [Malvaceae] ameliorate MAFLD via PI3K/AKT/mTOR-mediated autophagy. Frontiers in Pharmacology. 16. 1601707–1601707.
3.
Xu, Pan, Teng Liu, Min Zhang, et al.. (2024). Tumour vasculature at single-cell resolution. Nature. 632(8024). 429–436. 63 indexed citations breakdown →
5.
Huang, Lingjuan, Xianggui Wang, Shiyao Pei, et al.. (2023). Single-Cell Profiling Reveals Sustained Immune Infiltration, Surveillance, and Tumor Heterogeneity in Infiltrative Basal Cell Carcinoma. Journal of Investigative Dermatology. 143(11). 2283–2294.e17. 7 indexed citations
6.
Hu, Rui, Yao Li, Minghui Zhang, et al.. (2023). Combined BET and MEK Inhibition synergistically suppresses melanoma by targeting YAP1. Theranostics. 14(2). 593–607. 11 indexed citations
7.
Sun, Hongyin, et al.. (2023). Discovery of WD-890: A novel allosteric TYK2 inhibitor for the treatment of multiple autoimmune diseases. Biomedicine & Pharmacotherapy. 167. 115611–115611. 4 indexed citations
8.
Hu, Rui, Yao Li, Ying Guo, et al.. (2022). BRD4 inhibitor suppresses melanoma metastasis via the SPINK6/EGFR-EphA2 pathway. Pharmacological Research. 187. 106609–106609. 11 indexed citations
9.
Chen, Xisha, Kuansong Wang, Shilong Jiang, et al.. (2022). eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma. Journal for ImmunoTherapy of Cancer. 10(3). e004026–e004026. 31 indexed citations
10.
Yin, Mingzhu, Ying Guo, Rui Hu, et al.. (2020). Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction. Nature Communications. 11(1). 1833–1833. 115 indexed citations
12.
Akash, Muhammad Sajid Hamid, Kanwal Rehman, Hongyin Sun, & Shuqing Chen. (2013). Interleukin-1 receptor antagonist improves normoglycemia and insulin sensitivity in diabetic Goto-Kakizaki-rats. European Journal of Pharmacology. 701(1-3). 87–95. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026